Revvity Inc - Company Profile
Powered by 
All the data and insights you need on Revvity Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Revvity Inc Strategy Report
- Understand Revvity Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Revvity Inc (Revvity) provides reagents, instruments, consumables, software, informatics solutions, accessories and services to diagnostics, food, life science research, laboratory services, environmental, and industrial markets. It offers analytics, research, genetic screening, instrumentation and prenatal screening services for the early detection of genetic disorders, diagnosis of metabolic disorders, infectious disease testing, cancer treatment, drug discovery and various other research activities.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company's R&D activities are focused on improving its Diagnostics business and the environmental, life sciences research, food, and laboratory services industries in the Discovery & Analytical Solutions segment. In FY2022, Revvity spent US$221.6 million on its R&D, which as a percentage of revenue, stood at 6.7%, and grew 10.6% YoY.
Business Segments
Overview
Focused on emerging market diagnostics, reproductive health and applied genomics. It provides instruments, reagents, assay platforms, and software to medical labs, hospitals, clinicians, and medical research professionals. Its products are used to detect genetic abnormalities and various disorders and diseases, including hypothyroidism, Down syndrome, infertility, muscular dystrophy, and various metabolic conditions; and for applications in cancer and drug discovery. It also offers products and services for COVID-19 to support health authorities in the US and abroad. - Major products and services include in vitro diagnostic kit; Xpress screening platform; non-derivatized MS/MS AAAC kits; informatics data management solution; umbilical cord blood banking services; molecular-based infectious disease screening technologies; screening test for severe combined immunodeficiency; IVD kits; workstation for automated small scale purification; automated liquid handling platforms; automated workstation; rapid non-invasive preimplantation genetic testing kit and automated liquid handling platforms. Views product innovation as a critical growth driver for the segment. In line with this approach, in 2020, the company launched EONIS assay; LC 300 platform and Simplicity platform; respiratory SARS-CoV-2 RT-PCR panel; workstations for SARS-CoV-2 testing; and Xpress sFlt-1 kit.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides informatics, reagents, and detection and imaging technologies to the life sciences market; develops and provides analytical technologies, solutions and services to food, environmental and industrial markets; and offers analytical instrumentation to the industrial market. - Major products in environmental, food & industrial markets include sample-handling equipment; gas chromatographs/mass spectrometers; ultra-high performance liquid chromatography systems; high performance liquid chromatography systems; advanced liquid chromatography systems; gas chromatography/ mass spectrometry system; atomic spectroscopy family of instruments; spectrophotometers; infrared spectroscopy; thermogravimetric (TG) and simultaneous thermal analysis (STA) instruments; CHNS/O elemental analyzers; milk quality analyzers; and test kits - Major products in life sciences research and laboratory sector include radiometric detection solutions; high content screening system; high content analysis system; multimode plate reader benchtop system; multimode plate reader; homogeneous biochemical and cell based assay reagents; recombinant GPCR and Ion channel cell lines; research assays; biomarker detection kits; in vivo imaging technologies and reagents; translational data management, aggregation and analysis platform; interactive graphical platform; chemical structure drawing and visualization application; and scientific research data management solution Views product innovation as a critical growth driver for the segment.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer